Latest filing published 04 Dec 2024 for 넥스트바이오메디컬.
JPMorganAssetManagement(AsiaPacific)Limited: trading record in brief
JPMorganAssetManagement(AsiaPacific)Limited discloses dealings in 넥스트바이오메디컬 to DART (FSS). The record holds 2 filings, for trades running from 11 November 2024 to 29 November 2024.
The open-market side counts 1 purchase alongside 1 sale. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 4 December 2024, reports an open-market sale in 넥스트바이오메디컬. The most recent open-market purchase was published on 15 November 2024, 725 days ago. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Companies and markets linked to JPMorganAssetManagement(AsiaPacific)Limited
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,614 sharesKRXDART:20241204000221
- 410,345 sharesKRXDART:20241115000016Canonical exit: 13 Feb 2025 (T+90)
2 of 2 declarations